Clinical Trial Update: A Study to Evaluate the Safety and Tolerability, and the Efficacy of Si-544 in Adults With Psoriasis Vulgaris or Psoriatic Arthritis [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating safety, tolerability, and preliminary efficacy of Si-544 in adults with psoriasis vulgaris or psoriatic arthritis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis Vulgaris
• Psoriatic Arthritis

Drugs mentioned

• Si-544

Snippet

Sponsor: selectION Therapeutics GmbH | Conditions: Psoriasis Vulgaris, Psoriatic Arthritis | Phase 1 | Status: COMPLETED